AMERICAN BILLIONAIRE investor Charlie Munger once said that big money was not in buying and selling, but in the waiting. Rakesh Jhunjhunwala’s investment style echos this strategy. Case in point—his holding in Titan Company.
Jhunjhunwala began investing in the Tata Group-owned watch and jewellery maker back in 2002. And, in 20 years, its worth alone has risen to over 111,000 crore. Stock exchange data for the April to June quarter shows that Jhunjhunwala and his wife, Rekha, together held 4,48,50,970 shares of Titan, which gave them a 5.05 per cent stake in the company. Over the years, starting from 1985, Jhunjhunwala had built a portfolio of 32 stocks through the privately held RARE Enterprises. Apart from Titan, he and his wife also invested in several other Tata companies like Tata Motors DVR (2.95 per cent stake), Tata Communications (1.08 per cent), Rallis India (9.81 per cent) and Indian Hotels (2.12 per cent), indicating his faith in the Tata Group. “He had tremendous regard for the Tata Group,” noted N. Chandrasekaran, the chairman of Tata Sons, in his condolence message.
Jhunjhunwala’s other notable investments included ratings agency CRISIL (5.48 per cent stake), farm equipment maker Escorts, footwear company Metro Brands (14.4 per cent stake), gaming company Nazara Technologies (10.03 per cent stake), Aptech (23.37 per cent stake) and Fortis Healthcare (4.23 per cent stake). He also backed Star Health and Allied Insurance, in which he and his wife held 17.49 per cent stake.
His long-term bets have paid off; the day he died, on August 14, his net worth stood at over $5.8 billion, according to Forbes.
This story is from the August 28, 2022 edition of THE WEEK India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August 28, 2022 edition of THE WEEK India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Hat-Trick Or Has-Beens?
India look to win their third straight Test series in Australia, but ageing superstars and recent humiliation at home have cast a shadow on their hopes
Constipation Can Put Your Heart At Risk
PEOPLE WITH CONSTIPATION have an increased risk of major cardiac events, including heart attack, stroke and heart failure, especially if they also have high blood pressure, finds an international study published in the American Journal of Physiology-Heart and Circulatory Physiology.
Too Much Sitting Can Accelerate Ageing
SITTING FOR EXTENDED PERIODS can harm the heart and accelerate ageing, even if you are young and get the minimum recommended amount of daily exercise, according to a US study published in the journal PLOS One.
Efficiency and innovation
As health care evolves, professionals must employ innovative methods to refine their skills
Level up
Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres
HOPE STEMS FROM A CELL
While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries
Mind matters
Your mindset can limit or expand your physical ability
Cutting edge
Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.
The smallest cut
Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon
Signalling a revolution
Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin
